| Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation H Kebir, K Kreymborg, I Ifergan, A Dodelet-Devillers, R Cayrol, M Bernard, ... Nature medicine 13 (10), 1173-1175, 2007 | 1997 | 2007 |
| The promise of minocycline in neurology VW Yong, J Wells, F Giuliani, S Casha, C Power, LM Metz The Lancet Neurology 3 (12), 744-751, 2004 | 616 | 2004 |
| The role of inflammation in depression and fatigue CH Lee, F Giuliani Frontiers in immunology 10, 463031, 2019 | 474 | 2019 |
| Interleukin‐1β promotes oligodendrocyte death through glutamate excitotoxicity JL Takahashi, F Giuliani, C Power, Y Imai, VW Yong Annals of Neurology: Official Journal of the American Neurological …, 2003 | 325 | 2003 |
| Vulnerability of human neurons to T cell-mediated cytotoxicity F Giuliani, CG Goodyer, JP Antel, VW Yong The Journal of Immunology 171 (1), 368-379, 2003 | 280 | 2003 |
| Age‐related disability in multiple sclerosis M Trojano, M Liguori, G Bosco Zimatore, R Bugarini, C Avolio, D Paolicelli, ... Annals of Neurology: Official Journal of the American Neurological …, 2002 | 209 | 2002 |
| Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes C Avolio, M Ruggieri, F Giuliani, GM Liuzzi, R Leante, P Riccio, P Livrea, ... Journal of neuroimmunology 136 (1-2), 46-53, 2003 | 208 | 2003 |
| Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interaction F Giuliani, W Hader, VW Yong Journal of leukocyte biology 78 (1), 135-143, 2005 | 190 | 2005 |
| Changes of serum sICAM-1 and MMP-9 induced by rIFNβ-1b treatment in relapsing-remitting MS M Trojano, C Avolio, GM Liuzzi, M Ruggieri, G Defazio, M Liguori, ... Neurology 53 (7), 1402-1402, 1999 | 157 | 1999 |
| Additive effect of the combination of glatiramer acetate and minocycline in a model of MS F Giuliani, LM Metz, T Wilson, Y Fan, A Bar-Or, VW Yong Journal of neuroimmunology 158 (1-2), 213-221, 2005 | 133 | 2005 |
| Age at onset in multiple sclerosis M Ligouri, MG Marrosu, M Pugliatti, F Giuliani, F De Robertis, E Cocco, ... Neurological Sciences 21, S825-S829, 2000 | 108 | 2000 |
| Effective combination of minocycline and interferon-β in a model of multiple sclerosis F Giuliani, SA Fu, LM Metz, VW Yong Journal of neuroimmunology 165 (1-2), 83-91, 2005 | 105 | 2005 |
| Treatment optimization in multiple sclerosis: Canadian MS working group recommendations MS Freedman, V Devonshire, P Duquette, PS Giacomini, F Giuliani, ... Canadian Journal of Neurological Sciences 47 (4), 437-455, 2020 | 92 | 2020 |
| Interferon beta in relapsing-remitting multiple sclerosis: an independent postmarketing study in southern Italy M Trojano, M Liguori, D Paolicelli, GB Zimatore, F De Robertis, C Avolio, ... Multiple Sclerosis Journal 9 (5), 451-457, 2003 | 88 | 2003 |
| Granzyme B-inhibitor serpina3n induces neuroprotection in vitro and in vivo Y Haile, K Carmine-Simmen, C Olechowski, B Kerr, RC Bleackley, ... Journal of neuroinflammation 12, 1-10, 2015 | 77 | 2015 |
| Rab32 connects ER stress to mitochondrial defects in multiple sclerosis Y Haile, X Deng, C Ortiz-Sandoval, N Tahbaz, A Janowicz, JQ Lu, BJ Kerr, ... Journal of neuroinflammation 14, 1-13, 2017 | 72 | 2017 |
| Repression of phagocytosis by human CD33 is not conserved with mouse CD33 A Bhattacherjee, E Rodrigues, J Jung, M Luzentales-Simpson, ... Communications biology 2 (1), 450, 2019 | 67 | 2019 |
| Hydroxychloroquine reduces microglial activity and attenuates experimental autoimmune encephalomyelitis MW Koch, R Zabad, F Giuliani, W Hader Jr, R Lewkonia, L Metz, VW Yong Journal of the neurological sciences 358 (1-2), 131-137, 2015 | 54 | 2015 |
| Immune-mediated neurodegeneration and neuroprotection in MS. F Giuliani, VW Yong International MS Journal 10 (4), 122-130, 2003 | 49 | 2003 |
| Experimental models of neuroprotection relevant to multiple sclerosis VW Yong, F Giuliani, M Xue, A Bar-Or, LM Metz Neurology 68 (22_suppl_3), S32-S37, 2007 | 45 | 2007 |
